Ensign Peak Advisors, Inc
Position in ELAN — Elanco Animal Health Inc
CIK 1454984
SALT LAKE CITY, UT
Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,339,943
+$1,585,909 QoQ
Shares Held
95,081
+201.7% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#184
of 518 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in ELAN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,339,943 | 95,081 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $754,034 | 31,510 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $713,071 | 31,510 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,786,619 | 88,710 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,032,900 | 142,360 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,683,780 | 160,360 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,431,157 | 1,026,520 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,296,549 | 1,177,437 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,036,262 | 1,042,014 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,963,987 | 1,042,014 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,630,904 | 1,049,054 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $29,280,132 | 2,604,994 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,708,961 | 2,257,352 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,477,693 | 2,072,095 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,737,684 | 142,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,337,798 | 107,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,080,780 | 106,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,734,232 | 104,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,595,604 | 126,695 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,837,107 | 151,681 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,758,400 | 396,610 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $685,681 | 24,550 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,207,913 | 56,313 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||